These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 5252300)

  • 1. [On the tactics of myelosan therapy of chronic myeloleukosis].
    Kassirskiĭ IA; Volkova MA
    Ter Arkh; 1967 Feb; 39(2):3-9. PubMed ID: 5252300
    [No Abstract]   [Full Text] [Related]  

  • 2. [Kinetic constants of leukocyte reduction in the course of treatment of chronic myeloleukosis with different doses of myelosan].
    Levitin EI; Kukharenko IuA; Evsenko LS; Emanuel' NM
    Izv Akad Nauk SSSR Biol; 1968; 5():739-43. PubMed ID: 5262634
    [No Abstract]   [Full Text] [Related]  

  • 3. [The development of aplasia of hematopoiesis after the use of myelosan in patients with chronic myeloleukosis].
    Klimova NF; Cherntsova TA; Protasova TG
    Sov Med; 1967 Dec; 30(12):67-71. PubMed ID: 5250006
    [No Abstract]   [Full Text] [Related]  

  • 4. [Chronic myelogenous leukemia. Results of therapy with busulfan].
    Olesen J; Videbaek A
    Nord Med; 1969 Oct; 82(41):1284-90. PubMed ID: 5260856
    [No Abstract]   [Full Text] [Related]  

  • 5. [Myelosan (1,4-dimethanesulfoniloxybutane) and its significance in the therapy of chronic myeloleukosis].
    CHERNOV VA
    Klin Med (Mosk); 1958 Jul; 36(7):73-82. PubMed ID: 13576704
    [No Abstract]   [Full Text] [Related]  

  • 6. [Ambulatory treatment of patients with chronic myeloid leukemia].
    Lobanova NA
    Ter Arkh; 1981; 53(9):25-8. PubMed ID: 6946602
    [No Abstract]   [Full Text] [Related]  

  • 7. [Pregnancy during busulfan therapy of chronic granulocytic leukemia].
    Szentcsíki M; Brenner F; Balogh C; Hites L
    Orv Hetil; 1982 May; 123(21):1307-8. PubMed ID: 6955735
    [No Abstract]   [Full Text] [Related]  

  • 8. Treatment of chronic myeloleukosis with myelosan.
    PAVLOVSKAIA NI
    Klin Med (Mosk); 1958 Jul; 36(7):82-8. PubMed ID: 13576705
    [No Abstract]   [Full Text] [Related]  

  • 9. Method of treatment of chronic myeloleukosis with myelosan.
    MOKEEVA RA
    Klin Med (Mosk); 1958 Jul; 36(7):89-93. PubMed ID: 13576706
    [No Abstract]   [Full Text] [Related]  

  • 10. The possibility of radical chemotherapy in chronic myelocytic leukaemia.
    Galton DA
    Haematol Lat; 1969; 12(3):703-9. PubMed ID: 5273182
    [No Abstract]   [Full Text] [Related]  

  • 11. [Continual and periodic treatment of patients with chronic granulocytic leukemia].
    Colović M; Petrović M; Jancić MS; Banićević B; Vucić Lj; Janosević S; Ristić M
    Srp Arh Celok Lek; 1984 Apr; 112(4):487-93. PubMed ID: 6595809
    [No Abstract]   [Full Text] [Related]  

  • 12. [Use of the kinetic method for evaluation of the effectiveness of treating chronic leukemia patients with myelosan and degranol and their effect on the hemogram].
    Bala IuM; Rosnovskiĭ VS; Biriukova IV
    Probl Gematol Pereliv Krovi; 1971 May; 16(5):14-6. PubMed ID: 5292230
    [No Abstract]   [Full Text] [Related]  

  • 13. In vitro drug sensitivity studies of CFUc in chronic myelocytic leukemia: I. Suicide indices and busulfan sensitivity determinations during the chronic phase.
    Preisler HD; Kirshner J
    Exp Hematol; 1983 Aug; 11(7):618-25. PubMed ID: 6576910
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Chronic myeloid leukemia treated with busulfan. Clinical characteristics, prognostic factors, effect of treatment and survival in 82 cases].
    Larrain C; Cruz A; Codoceo V
    Rev Med Chil; 1984 Sep; 112(9):898-911. PubMed ID: 6598227
    [No Abstract]   [Full Text] [Related]  

  • 15. Treatment of 100 cases of chronic myeloid leukemia with Myleran.
    Pawelski S; Topolska P; Rechowicz K; Krzyzanowska-Wozniakowska
    Pol Med Sci Hist Bull; 1968 Jul; 11(3):101-4. PubMed ID: 5243952
    [No Abstract]   [Full Text] [Related]  

  • 16. Chronic myelosis treatment with Myleran (Myelosan).
    Atanasov K; Baltov I; Kirova V; Vakrilov V; Tzvetkova T
    Folia Med (Plovdiv); 1978; 20(1):54-8. PubMed ID: 104910
    [No Abstract]   [Full Text] [Related]  

  • 17. [Serious hematological accidents due to Myleran in the treatment of chronic myeloid leukemia].
    Olmer J; Muratore R; Gabriel B; Canu AM
    Mars Med; 1968; 105(4):330-8. PubMed ID: 5245481
    [No Abstract]   [Full Text] [Related]  

  • 18. Continuous infusion idarubicin and oral busulfan as conditioning for patients with acute myeloid leukemia aged over 60 years undergoing autologous stem cell transplantation.
    Ferrara F; Palmieri S; Annunziata M; Viola A; Pocali B; Califano C; D'Arco AM; Mele G
    Bone Marrow Transplant; 2004 Oct; 34(7):573-6. PubMed ID: 15258559
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Myelobromol treatment of patients with chronic myeloleukosis].
    Cherntsova TA; Klimova NF; Susoeva VM
    Klin Med (Mosk); 1967 Jul; 45(7):96-104. PubMed ID: 5250315
    [No Abstract]   [Full Text] [Related]  

  • 20. Combination chemotherapy for chronic granulocytic leukaemia.
    Resegotti L; Dolci C
    Haematologica; 1981 Oct; 66(5):709-10. PubMed ID: 6796479
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.